Outcomes of a telemonitoring-based program (telEPOC) in frequently hospitalized COPD patients

Autor: Esteban C, Moraza J, Iriberri M, Aguirre U, Goiria B, Quintana JM, Aburto M, Capelastegui A

Publikováno v: International Journal of COPD, Vol Volume 11, Pp 2919-2930 (2016)

Cristóbal Esteban,1,2 Javier Moraza,1 Milagros Iriberri,3 Urko Aguirre,2,4 Begoña Goiria,5 José M Quintana,2,4 Myriam Aburto,1 Alberto Capelastegui1 1Pneumology Department, Galdakao-Usansolo Hospital, Galdakao, 2Red de Investigación en Servicios

Externí odkaz: https://doaj.org/article/091c5713211746bd9eba756af0e80308

Short- and long-term prognosis of patients with community-acquired Legionella or pneumococcal pneumonia diagnosed by urinary antigen testing.

Autor: Serrano L; Pulmonology Service, Hospital Universitario Cruces, Barakaldo, Bizkaia, Spain; Department of Immunology, Microbiology, and Parasitology. Facultad de Medicina y Enfermería, Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), Leioa, Spain; BioCruces Bizkaia Health Research Institute, Barakaldo, Spain. Electronic address: leyre.serranofernandez@osakidetza.eus., Ruiz LA; Pulmonology Service, Hospital Universitario Cruces, Barakaldo, Bizkaia, Spain; BioCruces Bizkaia Health Research Institute, Barakaldo, Spain; Department of Medicine. Facultad de Medicina y Enfermería, Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), Leioa, Spain., Perez-Fernandez S; Bioinformatics and Statistics Unit, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain., España PP; Pulmonology Service, Hospital Universitario Galdakao-Usansolo, Galdakao, Spain., Gomez A; Pulmonology Service, Hospital Universitario Cruces, Barakaldo, Bizkaia, Spain; BioCruces Bizkaia Health Research Institute, Barakaldo, Spain., Gonzalez B; Pulmonology Service, Hospital Universitario Cruces, Barakaldo, Bizkaia, Spain; BioCruces Bizkaia Health Research Institute, Barakaldo, Spain., Uranga A; Pulmonology Service, Hospital Universitario Galdakao-Usansolo, Galdakao, Spain., Castro S; Pulmonology Service, Hospital Universitario Cruces, Barakaldo, Bizkaia, Spain; BioCruces Bizkaia Health Research Institute, Barakaldo, Spain; Department of Medicine. Facultad de Medicina y Enfermería, Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), Leioa, Spain., Iriberri M; Pulmonology Service, Hospital Universitario Cruces, Barakaldo, Bizkaia, Spain; BioCruces Bizkaia Health Research Institute, Barakaldo, Spain., Zalacain R; Pulmonology Service, Hospital Universitario Cruces, Barakaldo, Bizkaia, Spain; BioCruces Bizkaia Health Research Institute, Barakaldo, Spain.

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2023 Sep; Vol. 134, pp. 106-113. Date of Electronic Publication: 2023 Jun 01.

Correction to: Predictors of short‑term COPD readmission.

Autor: Quintana JM; Unidad de Investigación, Hospital Galdakao-Usansolo, Barrio Labeaga S/N, 48960, Galdakao, Vizcaya, Spain. josemaria.quintanalopez@osakidetza.eus.; Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), Barakaldo, Vizcaya, Spain. josemaria.quintanalopez@osakidetza.eus.; Instituto Kronikgune, Barakaldo, Vizcaya, Spain. josemaria.quintanalopez@osakidetza.eus., Anton-Ladislao A; Unidad de Investigación, Hospital Galdakao-Usansolo, Barrio Labeaga S/N, 48960, Galdakao, Vizcaya, Spain.; Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), Barakaldo, Vizcaya, Spain.; Instituto Kronikgune, Barakaldo, Vizcaya, Spain., Orive M; Departamento Psicología Social, Facultad Farmacia, UPV/EHU, Vitoria-Gasteiz, Spain.; Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), Barakaldo, Vizcaya, Spain.; Instituto Kronikgune, Barakaldo, Vizcaya, Spain., Aramburu A; Servicio de Respiratorio, Hospital Universitario Galdakao-Usansolo, Galdakao, Spain.; Instituto BioCruces-Bizkaia, Barakaldo, Vizcaya, Spain., Iriberri M; Servicio de Respiratorio, Hospital Universitario de Cruces, Barakaldo, Vizcaya, Spain.; Instituto BioCruces-Bizkaia, Barakaldo, Vizcaya, Spain., Sánchez R; Servicio de Respiratorio, Hospital Universitario de Basurto, Bilbao, Vizcaya, Spain., Jiménez-Puente A; Unidad de Evaluación, Hospital Costa del Sol, Marbella, Málaga, Spain., de-Miguel-Díez J; Servicio de Respiratorio, Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.; Universidad Complutense de Madrid, Madrid, Spain., Esteban C; Servicio de Respiratorio, Hospital Universitario Galdakao-Usansolo, Galdakao, Spain.; Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), Barakaldo, Vizcaya, Spain.; Instituto BioCruces-Bizkaia, Barakaldo, Vizcaya, Spain.

Publikováno v: Internal and emergency medicine [Intern Emerg Med] 2023 Aug; Vol. 18 (5), pp. 1609.

An NMR-Based Model to Investigate the Metabolic Phenoreversion of COVID-19 Patients throughout a Longitudinal Study.

Autor: Gil-Redondo R; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain., Conde R; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain., Bizkarguenaga M; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain., Bruzzone C; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain., Laín A; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain., González-Valle B; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain., Iriberri M; Pneumology Department, Hospital Universitario de Cruces, 48903 Barakaldo, Spain., Ramos-Acosta C; Department of Medicine, Faculty of Medicine, UCM, Hematology Department, IML, IdISSC, Hospital Clínico San Carlos, 28040 Madrid, Spain., Anguita E; Department of Medicine, Faculty of Medicine, UCM, Hematology Department, IML, IdISSC, Hospital Clínico San Carlos, 28040 Madrid, Spain., Arriaga Lariz JI; Pneumology Department, Hospital Universitario de Basurto, 48013 Bilbao, Spain., España Yandiola PP; Pneumology Department, Hospital Universitario de Galdakao-Usansolo, 48960 Galdakao, Spain., Moran MÁ; Bioaraba Health Research Institute, 01009 Vitoria-Gasteiz, Spain.; Internal Medicine Department, Infectious Diseases Section, Osakidetza Basque Health Service, Araba University Hospital, 01009 Vitoria-Gasteiz, Spain., Jiménez-Mercado ME; Bioaraba Health Research Institute, 01009 Vitoria-Gasteiz, Spain.; Emergency Department, Osakidetza Basque Health Service, Araba University Hospital, 01009 Vitoria-Gasteiz, Spain., Egia-Mendikute L; Cancer Immunology and Immunotherapy Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain., Seco ML; OSARTEN Kooperatiba Elkartea, 20500 Arrasate-Mondragón, Spain., Schäfer H; Bruker Biospin GmbH, Silberstreifen, 76287 Rheinstetten, Germany., Cannet C; Bruker Biospin GmbH, Silberstreifen, 76287 Rheinstetten, Germany., Spraul M; Bruker Biospin GmbH, Silberstreifen, 76287 Rheinstetten, Germany., Palazón A; Cancer Immunology and Immunotherapy Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain.; Ikerbasque, Basque Foundation for Science, 48015 Derio, Spain., Embade N; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain., Lu SC; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Wist J; Australian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.; Chemistry Department, Universidad del Valle, Cali 76001, Colombia., Nicholson JK; Australian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.; Medical School, Faculty of Health and Medical Sciences, University of Western Australia, Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Perth, WA 6150, Australia.; Institute of Global Health Innovation, Faculty of Medicine, Imperial College London, Level 1, Faculty Building, South Kensington Campus, London SW7 2NA, UK., Mato JM; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain.; CIBERehd, Instituto de Salud Carlos III, 28029 Madrid, Spain., Millet O; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain.; CIBERehd, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Publikováno v: Metabolites [Metabolites] 2022 Dec 01; Vol. 12 (12). Date of Electronic Publication: 2022 Dec 01.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.